Cassidy RJ, et al. Richard Cassidy A majority of patients with stage III lung cancer aged older than 80 years received no cancer-directed therapy, according to study results published in Cancer. Further, black race and residence in a lower-educated census tract increased likelihood of not receiving care. This may provide information to guide outreach programs to engage the elderly community in seeking appropriate therapy for stage III lung cancer.
Patients aged 65 years and older are living longer after lung cancer surgery, and with older people representing a rapidly growing proportion of patients diagnosed with lung cancer, this improved survival is especially significant, according to an article posted online today by The Annals of Thoracic Surgery.. Key findings in this study show that 5-year survival for older lung cancer surgery patients is favorable; surgeons will be able to better individualize care for older lung cancer patients based on newly and uniquely linked data, and the prevalence of lung cancer is expected to increase as the population continues to age. This information can be included in the shared decision-making process when discussing treatment options with patients. The GTSD data included 37, records for patients 65 years of age and older who underwent lung cancer surgery between and When merged with CMS data, the records of 26, patients were successfully linked, providing access to vital information related to long-term patient outcomes. This included hospital readmission rates, reinterventions a second procedure , and long-term survival.
Lung cancer mostly affects the elderly. It is most commonly diagnosed among people years of age. Between ,
Lung cancer in older adults is treatable just as in younger adults, and many people are surprised to hear that many potential treatments are well tolerated by people who are 80 years of age, 90 years of age, or older. With early-stage non-small cell lung cancers, surgery especially some procedures and surgical methods is tolerated quite well, though an alternative to surgery that is much less invasive, stereotactic body radiotherapy SBRT is an option that likewise offers the chance of a cure. For more advanced cancers, the newer targeted therapies as well as immunotherapy drugs are often much better tolerated than chemotherapy, and in many cases, more effective.